Skip to main content
Editorial31 March 2022
Editorial: Emerging Therapeutic Approaches for Repair and Regeneration of Injuries in the Peripheral Nervous System

The special issue research topic entitled "Bio-systems engineering for regulation of nerve regeneration" is focused on new and emerging approaches for promoting nerve regeneration.Acute and chronic nerve injuries often result in the loss of sensory, motor and autonomic functions with variable pathological changes arising from traumatic or non-traumatic forms of injuries. Despite the severe consequences of such injuries for the patients, existing treatment options, i.e., surgical repair, often using autologous nerve grafting, and pharmacological compounds, such as corticosteroids, nonsteroidal anti-inflammatory and analgesic drugs, are all associated with important drawbacks and are far from being optimal solutions. Consequently, the quality of patient's life is poor and the resulting socioeconomic impact is huge. Thus, there is a great need for further research to advance with new and innovative treatment strategies for improving functional recovery and patient wellbeing and to minimize the socioeconomic burden.So far, research over the past 100 years has achieved remarkable achievements in the field of nerve regeneration, resulting in the advancement of micro-surgical nerve management, nerve cellular and molecular biology, nerve guidance scaffolds, cell therapy and nerve tissue engineering. Nevertheless, the existing knowledge and translational modalities still remain inadequate for clinical applications. Within this context, the collected research articles in this issue represent the work of 62 different authors in the form of three review articles and six original research reports, presenting new and emerging strategies involving interdisciplinary efforts ranging from cell and molecular biology, engineered nano-micromaterials, bio-active delivery, cell and gene therapy, tissue engineered grafts, and complex nerve conduit scaffolds.Taken together, the collected research reports strengthen existing knowledge in the field and provide further insights to move forward. Growth factors are widely accepted for their key role in regulating tissue growth and development. However, the current lack of appropriate delivery scaffolds and strategies has limited their therapeutic potential. In their review, Salvin et al. present the therapeutic potential of insulin-like growth factor-1, known for its trophic and protective effects on neuronal and non-neuronal glial cells. In addition, the review offers important insights on the most promising delivery routes and dosage forms for supporting nerve regeneration. Spinal root (ventral root) avulsion is critical and represents the most serious proximal nerve injury, given the fact that the distance between the lesion and target innervation site is too long and often results in a permanent loss of motor function. Among all the neurotrophic factors, glial cell linederived neurotrophic factor (GDNF) is the most potent for the survival and growth of motor axons. In another review by Egger et al., recent advances in the field of GDNF gene therapy are presented, as well as future research directions emphasizing the importance of the spatio-temporal aspects of the therapeutic intervention, such as the location, timing, dose and duration of GDNF.The extracellular matrix composition of nerve tissue is complex in nature and architecture. Biomaterials and bio-based research approaches are promising for recapitulating the key features and for instructing the sequence of cellular and molecular events of the axonal regeneration and nerve tissue formation. However, the detailed mechanisms underlying the interface regulation between engineered biomaterials and nerve tissue components are largely unclear. In a detailed review article, Powel et al. present such mechanisms with further information on the cell controllable micro-environment resulting from engineered bio-active biomaterials.In summary, we consider that all the articles included in the current issue provide new and interesting data and important insights for further research in the field, particularly regarding the interdisciplinary aspects of nerve repair and regeneration approaches. The guest editors of this special issue thank all authors once again for their valuable contributions and hope that the readers in the field will be inspired by these significant research findings and expert opinions.

1,596 views

1 citations

11,637 views

55 citations

ORIGINAL RESEARCH
9 December 2021
Micropatterned Poly(D,L-Lactide-Co-Caprolactone) Conduits With KHI-Peptide and NGF Promote Peripheral Nerve Repair After Severe Traction Injury
Xing Yu, 6 more and Yong Wang

3,378 views

9 citations

Tissue Engineered Bands of Büngner for Accelerated Motor and Sensory Axonal Outgrowth
ORIGINAL RESEARCH
20 November 2020
Tissue Engineered Bands of Büngner for Accelerated Motor and Sensory Axonal Outgrowth
Kate V. Panzer, 6 more and D. Kacy Cullen
Following peripheral nerve injury comprising a segmental defect, the extent of axon regeneration decreases precipitously with increasing gap length. Schwann cells play a key role in driving axon re-growth by forming aligned tubular guidance structures called bands of Büngner, which readily occurs in distal nerve segments as well as within autografts – currently the most reliable clinically-available bridging strategy. However, host Schwann cells generally fail to infiltrate large-gap acellular scaffolds, resulting in markedly inferior outcomes and motivating the development of next-generation bridging strategies capable of fully exploiting the inherent pro-regenerative capability of Schwann cells. We sought to create a preformed, implantable Schwann cell-laden microtissue that emulates the anisotropic structure and function of naturally-occurring bands of Büngner. Accordingly, we developed a biofabrication scheme leveraging biomaterial-induced self-assembly of dissociated rat primary Schwann cells into dense, fiber-like three-dimensional bundles of Schwann cells and extracellular matrix within hydrogel micro-columns. This engineered microtissue was found to be biomimetic of morphological and phenotypic features of endogenous bands of Büngner, and also demonstrated 8x and 2x faster rates of axonal extension in vitro from primary rat spinal motor neurons and dorsal root ganglion sensory neurons, respectively, compared to 3D matrix-only controls or planar Schwann cells. To our knowledge, this is the first report of accelerated motor axon outgrowth using aligned Schwann cell constructs. For translational considerations, this microtissue was also fabricated using human gingiva-derived Schwann cells as an easily accessible autologous cell source. These results demonstrate the first tissue-engineered bands of Büngner (TE-BoBs) comprised of dense three-dimensional bundles of longitudinally aligned Schwann cells that are readily scalable as implantable grafts to accelerate axon regeneration across long segmental nerve defects.

15,899 views

82 citations

GDNF Gene Therapy to Repair the Injured Peripheral Nerve
A spinal root avulsion is the most severe proximal peripheral nerve lesion possible. Avulsion of ventral root filaments disconnects spinal motoneurons from their target muscles, resulting in complete paralysis. In patients that undergo brachial plexus nerve repair, axonal regeneration is a slow process. It takes months or even years to bridge the distance from the lesion site to the distal targets located in the forearm. Following ventral root avulsion, without additional pharmacological or surgical treatments, progressive death of motoneurons occurs within 2 weeks (Koliatsos et al., 1994). Reimplantation of the avulsed ventral root or peripheral nerve graft can act as a conduit for regenerating axons and increases motoneuron survival (Chai et al., 2000). However, this beneficial effect is transient. Combined with protracted and poor long-distance axonal regeneration, this results in permanent function loss. To overcome motoneuron death and improve functional recovery, several promising intervention strategies are being developed. Here, we focus on GDNF gene-therapy. We first introduce the experimental ventral root avulsion model and discuss its value as a proxy to study clinical neurotmetic nerve lesions. Second, we discuss our recent studies showing that GDNF gene-therapy is a powerful strategy to promote long-term motoneuron survival and improve function when target muscle reinnervation occurs within a critical post-lesion period. Based upon these observations, we discuss the influence of timing of the intervention, and of the duration, concentration and location of GDNF delivery on functional outcome. Finally, we provide a perspective on future research directions to realize functional recovery using gene therapy.

8,211 views

42 citations

ORIGINAL RESEARCH
10 July 2020
Development and Characterisation of an in vitro Model of Wallerian Degeneration
Heba Elsayed, 8 more and Adam J. Reid

7,057 views

14 citations